Articles
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
Manufacturing & OperationsSchreiner MediPharm’s Innovative Label Enhances WuXi XDC’s Clinical Trials
4 min read • 2 years ago -
-
Manufacturing ServicesAdragos Pharma Expands Sterile Manufacturing Prowess with Swiss Acquisition
4 min read • 2 years ago -
-
-
Manufacturing ServicesGSK and Vesalius Therapeutics Partner to Advance Parkinson’s Research
4 min read • 2 years ago -
Manufacturing ServicesBioNTech to Acquire Biotheus to Strengthen Oncology Pipeline
4 min read • 2 years ago -
NewsMetsera Secures USD 215 Million to Advance Obesity Treatments and GLP-1 Drug Development
4 min read • 2 years ago -
NewsAstraZeneca Commits USD 3.5 Billion to U.S. Biopharmaceutical Expansion
4 min read • 2 years ago -
-
Funding & InvestmentsCould CDMOs Replace the Need for Biopharma Incubators?
4 min read • 2 years ago -
Manufacturing ServicesPrivate Equity Firms Acquire Biologics CDMO Avid Bioservices
4 min read • 2 years ago
Join 50,000+ Pharma Professionals
Receive exclusive market analysis, biotech trends, regulatory intelligence, and executive briefings.
Advertisement here
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are.







